Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression: a review of the evidence

被引:33
作者
Downing, SR
Jackson, P
Russell, PJ
机构
[1] Prince Wales Hosp, Oncol Res Ctr, Randwick, NSW 2031, Australia
[2] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia
来源
UROLOGIC ONCOLOGY | 2001年 / 6卷 / 03期
关键词
p53; mutations; prostate cancer; tumour progression;
D O I
10.1016/S1078-1439(00)00119-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the p53 tumour suppressor gene are generally believed to be a late event in the progression of prostate cancer, and are associated with androgen independence, metastasis. and a worse prognosis. In this review, we examine the current literature available on p53 mutations and focus on stages A (T1) and B (T2) of prostate cancer. We report here that p53 mutations can he found in approximately one third of prostate cancers that are clinically localized to the prostate. In addition, high levels of p53 mutation are found in normal prostate tissue of prostate cancer patients, prostatic intracpithelial neoplasia, and benign prostatic hyperplasia. The limitations of techniques used to determine p53 mutations are discussed. as well as other modes of p53 loss in early stage prostate cancer. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:103 / 110
页数:8
相关论文
共 130 条
  • [61] Loss of heterozygosity of the TP53 tumor suppressor gene and detection of point mutations by the non-isotopic RNAse cleavage assay in prostate cancer
    Macera, MJ
    Godec, CJ
    Sharma, N
    Verma, RS
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 108 (01) : 42 - 47
  • [62] PROSTATE AND MAMMARY ADENOCARCINOMA IN TRANSGENIC MICE CARRYING A RAT C3(1) SIMIAN-VIRUS-40 LARGE TUMOR-ANTIGEN FUSION GENE
    MAROULAKOU, IG
    ANVER, M
    GARRETT, L
    GREEN, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 11236 - 11240
  • [63] MASSENKEIL G, 1994, ANTICANCER RES, V14, P2785
  • [64] HIGH PREVALENCE OF HUMAN PAPILLOMAVIRUS IN PROSTATE TISSUES
    MCNICOL, PJ
    DODD, JG
    [J]. JOURNAL OF UROLOGY, 1991, 145 (04) : 850 - 853
  • [65] DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN PROSTATE-GLAND TISSUE BY USING THE POLYMERASE CHAIN-REACTION AMPLIFICATION ASSAY
    MCNICOL, PJ
    DODD, JG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) : 409 - 412
  • [66] P53 MUTATIONS IN BENIGN PROSTATIC HYPERPLASIA
    MEYERS, FJ
    CHI, SG
    FISHMAN, JR
    WHITE, RWD
    GUMERLOCK, PH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (22) : 1856 - 1858
  • [67] Meyers FJ, 1998, CANCER, V83, P2534, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2534::AID-CNCR19>3.3.CO
  • [68] 2-M
  • [69] MIRCHANDANI D, 1995, AM J PATHOL, V147, P92
  • [70] The MDM2 gene amplification database
    Momand, J
    Jung, D
    Wilczynski, S
    Niland, J
    [J]. NUCLEIC ACIDS RESEARCH, 1998, 26 (15) : 3453 - 3459